Loading company…
OxSyBio Ltd., founded in 2014 in London, develops synthetic biology solutions for medical therapies and regenerative medicine.
Founded in 2014 and headquartered in London, UK, OxSyBio generates revenue mainly through research and development partnerships with research institutions and healthcare organizations. The company has completed three funding deals, most recently a GBP 5.000 mn Series A round led by Woodford Patient Capital Trust on February 20, 2018. Total funding raised stands at GBP 5.000 mn, with a company valuation of GBP 19.550 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in